Edward Oates, Partner, Carpmaels & Ransford LLP to Speak at the Knowledge Group’s Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries
Edward Oates, Partner, Carpmaels & Ransford LLP to Speak at the Knowledge Group’s Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries in 2016 Live Webcast
New York, NY, January 09, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Edward Oates, Partner, Carpmaels & Ransford LLP will speak at the Knowledge Group’s webcast entitled: “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries in 2016.” This event is scheduled for March 31, 2016 from 12:00pm – 2:00pm (ET).
For further details, please visit: https://theknowledgegroup.org/strategic-patent-portfolio-and-lifecycle-development-for-pharma-biotech-industries-in-2016-live-webcast-2/
About Edward Oates
Ed practises in the life sciences field, with a particular focus on pharmaceuticals, from small molecule inventions through to later stage developments. He has worked on numerous marketed products across a variety of fields, including some of the world’s most commercially successful medicines of recent times.
When not prosecuting patents or engaged in contentious work, Ed uses his knowledge of the pharmaceutical industry and his experience on big-ticket cases to give practical advice to life sciences clients of all sizes in relation to IP matters. This includes freedom-to-operate advice and transactional support, such as due diligence.
One of Ed’s areas of special interest is patent lifecycle management, and he advises clients on supplementary protection certificates (SPCs), paediatric extensions and regulatory exclusivities. He has an extremely detailed knowledge of SPC law, and has coordinated many complex pan-European SPC portfolios.
About Carpmaels & Ransford LLP
Carpmaels & Ransford LLP is a leading firm of European patent attorneys. At the vanguard of intellectual property for over 200 years, our pioneering roots in London now extend to Munich and around the globe.
We have been at the forefront of biotechnology right from the start when we started prosecuting cases originating mainly from the West Coast of the US.
Our broad-based technical expertise is organised into dedicated teams with key technical and professional skills specific to both emerging and established industries. Each team represents a pool of specialist knowledge where developments in the law and technology are closely followed. We believe it’s the depth of our expertise, the range of our experience, the huge pride in what we deliver to our clients and our supportive approach to problem solving that marks us out.
For more information, please see www.carpmaels.com
Event Synopsis:
Generic competition relentlessly poses a threat for pharma and biotech lifecycles. With its growing complexity, companies with poor product lifecycle management strategies are more likely to be exposed to legal challenges and revenue risks. Thus, it is crucial for companies to establish and maintain a robust life cycle management strategy to minimize possible loss and liabilities.
In a two-hour live webcast, a panel of key thought leaders, professionals and regulators assembled by The Knowledge Group will help the audience understand the most significant issues with respect to portfolio strategies in pharmaceutical and biotechnology patent lifecycle management and development. The panel will also share their expertise and insights on how to best maintain an effective and efficient patent portfolio in biotech and pharma lifecycle.
Key topics include:
− Pharmaceutical and Biotechnology Patent Life Cycles – An Overview
− Patent Term Adjustments for Biotech and Pharma
− Role of PTA in Biotech and Pharma Patent Life Cycle
− Patent Term Extensions, including SPCs in Europe
− Patentability and Implications for Life Sciences Innovation
− Portfolio Strategies
− Common Risks and Pitfalls
− Up-to-the-minute Regulatory Updates
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
For further details, please visit: https://theknowledgegroup.org/strategic-patent-portfolio-and-lifecycle-development-for-pharma-biotech-industries-in-2016-live-webcast-2/
About Edward Oates
Ed practises in the life sciences field, with a particular focus on pharmaceuticals, from small molecule inventions through to later stage developments. He has worked on numerous marketed products across a variety of fields, including some of the world’s most commercially successful medicines of recent times.
When not prosecuting patents or engaged in contentious work, Ed uses his knowledge of the pharmaceutical industry and his experience on big-ticket cases to give practical advice to life sciences clients of all sizes in relation to IP matters. This includes freedom-to-operate advice and transactional support, such as due diligence.
One of Ed’s areas of special interest is patent lifecycle management, and he advises clients on supplementary protection certificates (SPCs), paediatric extensions and regulatory exclusivities. He has an extremely detailed knowledge of SPC law, and has coordinated many complex pan-European SPC portfolios.
About Carpmaels & Ransford LLP
Carpmaels & Ransford LLP is a leading firm of European patent attorneys. At the vanguard of intellectual property for over 200 years, our pioneering roots in London now extend to Munich and around the globe.
We have been at the forefront of biotechnology right from the start when we started prosecuting cases originating mainly from the West Coast of the US.
Our broad-based technical expertise is organised into dedicated teams with key technical and professional skills specific to both emerging and established industries. Each team represents a pool of specialist knowledge where developments in the law and technology are closely followed. We believe it’s the depth of our expertise, the range of our experience, the huge pride in what we deliver to our clients and our supportive approach to problem solving that marks us out.
For more information, please see www.carpmaels.com
Event Synopsis:
Generic competition relentlessly poses a threat for pharma and biotech lifecycles. With its growing complexity, companies with poor product lifecycle management strategies are more likely to be exposed to legal challenges and revenue risks. Thus, it is crucial for companies to establish and maintain a robust life cycle management strategy to minimize possible loss and liabilities.
In a two-hour live webcast, a panel of key thought leaders, professionals and regulators assembled by The Knowledge Group will help the audience understand the most significant issues with respect to portfolio strategies in pharmaceutical and biotechnology patent lifecycle management and development. The panel will also share their expertise and insights on how to best maintain an effective and efficient patent portfolio in biotech and pharma lifecycle.
Key topics include:
− Pharmaceutical and Biotechnology Patent Life Cycles – An Overview
− Patent Term Adjustments for Biotech and Pharma
− Role of PTA in Biotech and Pharma Patent Life Cycle
− Patent Term Extensions, including SPCs in Europe
− Patentability and Implications for Life Sciences Innovation
− Portfolio Strategies
− Common Risks and Pitfalls
− Up-to-the-minute Regulatory Updates
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories